Contact
Please use this form to send email to PR contact of this press release:
Alzheimer Treatment Developer Neuronix Files for IPO
TO:
Please use this form to send email to PR contact of this press release:
Alzheimer Treatment Developer Neuronix Files for IPO
TO: